Statistics published for all routine childhood vaccinations in England in 2019-20
Notes for editors
- Coverage is defined as the number of persons immunised as a proportion of the eligible population. The formula for the calculation of coverage is: (Total number of eligible persons immunised / Total number of persons in eligible population) x 100
- Vaccinations measured at 12 months, 24 months or 5 years in England in 2019-20, compared to the previous year. Some vaccinations have their coverage measured at all of these ages while others are just measured at one or two of them. The increase ranged in size from 0.2 to 0.9 percentage points. Coverage for MMR1 at 5 years remained the same as the previous year. The only coverage measure to decrease was the 5-in-1 / 6-in-1 at 24 months. See page 11 of the report for more information.
- Data on 14 routine childhood vaccination measurements is included in this report; these measurements relate to 10 vaccinations. In addition, data are published for two selective neonatal vaccination programmes (BCG and hepatitis B) and flu.
- The MMR vaccine was introduced in 1988 and the highest level of coverage at 24 months was 92.7% in 2013-14. The lowest was in 2003-04 when coverage was 79.9%.
- The nine regions are: North East, North West, Yorkshire & Humber, East Midlands, West Midlands, East of England, London, South East and South West.
- In September 2017, the 5-in-1 vaccine was replaced with a 6-in-1 vaccine, adding protection against hepatitis B for all babies born after 1 August 2017.
- Any children born or vaccinated in 2018-19 would have received the 6-in-1. This represents the 12-month cohort in the 2019-20 report.
- Any children vaccinated in 2017-18 will have received either the 5-in-1 vaccine or the 6-in-1 vaccine, depending on when in the year they were vaccinated. For the purposes of this report, children receiving either of these vaccinations will be included within the 5-in-1 numbers. This change mainly affects the 24-month cohort who were all born in 2017-18, it does not significantly impact the five-year age cohorts as most of these children will have been vaccinated prior to the introduction of the 6-in-1 vaccine.
- Meningococcal group B (MenB) vaccine was introduced into the routine immunisation programme in September 2015 and is offered at 8 and 16 weeks of age with a booster after the first birthday.
- Further information on vaccinations is available on the NHS website.
- For media enquiries please contact firstname.lastname@example.org or telephone 0300 30 33 888. Follow us on Twitter: @NHSDigital
Last edited: 24 September 2020 8:12 am